Table 1.
Baseline clinical characteristics of the patients
|
Characteristic
|
n = 16
|
| Age (yr) | 52.5 ± 7.91 |
| Male | 12 |
| Female | 4 |
| Duration of diabetes (yr) | 10.06 ± 5.74 |
| BMI (kg/m2) | 24.47 ± 2.76 |
| Glucose (mmol/L) | |
| FPG | 9.66 ± 2.65 |
| P2PG | 16.32 ± 4.64 |
| HbA1c (%) | 8.01 ± 0.63 |
| C peptide (pmol/L) | |
| FCP | 741.56 ± 464.50 |
| P2CP | 1596.70 ± 989.65 |
| HOMA-IR | 4.22 ± 1.91 |
| HOMA-β (%) | 35.01 ± 24.35 |
BMI: Body mass index; FPG: Fasting plasma glucose; P2PG: 2-h postprandial plasma glucose; HbA1c: Glycosylated hemoglobin; FCP: Fasting c-peptide; P2CP: 2-h postprandial c-peptide; HOMA-IR: Homeostasis model assessment of insulin resistance; HOMA-β: Homeostasis model assessment of β-cell function.